Logo Image
News|Articles|October 3, 2025

Q3 2025 Recap: Nephrology News and Updates

Fact checked by: Ryan Livingston

The Q3 recap for nephrology spotlights key FDA decisions, new KDIGO IgA nephropathy guidelines, and other top renal news and research.

The third quarter of 2025 brought several regulatory updates, clinical guideline updates, and notable renal research, underscoring the rapidly evolving landscape in nephrology. From IgA nephropathy (IgAN) and C3 glomerulopathy (C3G) to focal segmental glomerulosclerosis (FSGS) and xenotransplantation, a string of US Food and Drug Administration actions—including approvals, label updates, and advisory committees —signal increasing momentum for therapeutic innovation across a range of kidney diseases.